We have constructed a plasmid containing the gene for production of the B subunit of the heat-labile enterotoxin (LT-B) from a human isolate of Escherichia coli, strain H10407. The 0.8-kilobase gene fragment encoding synthesis of LT-B was cloned onto plasmid pBR322 after sequential digestion of the enterotoxin plasmid of strain H10407 with restriction endonucleases PstI and HindIll. LT-B was isolated by agarose affinity chromatography from cell lysates of recombinant clones expressing the B subunit. The B subunit was isolated in its oligomeric form, was structurally identical to native B subunit when examined by sodium dodecyl sulfate-polyacrylamide gel electrophoresis, dissociated to monomeric B in the presence of 5 M guanidine, was immunologically identical to native B subunit in an enzyme-linked immunosorbent assay, and contained no demonstrable A subunit in any of the assays.
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Escherichia coli produces diarrhea by a variety of mechanisms, including invasion of the intestinal epithelium or production of one or more enterotoxins. One of these enterotoxins, the heat-labile toxin (LT), has been purified and is known to be inmmunologically and physicochemically related to the enterotoxin of Vibrio cholerae (choleragen) (4, 6, 18) . Enterotoxigenic E. coli strains have been isolated from a number of different animals, including humans (9, 13, 14, (23) (24) (25) , and recent investigations in a number of laboratories have revealed remarkable similarities between LTs isolated from strains of human and animal origin (11, 12, 16) . Immunological differences between these have been noted, however, and we have recently demonstrated that these differences reside principally in the B subunit of the enterotoxin (5) .
The enterotoxins of E. coli are plasmid mediated, and the plasmids that encode LT are large, at least 50 x 106 daltons in mass (25) and Dallas and Falkow (7) established the precise orientation of the genes for each of the subunits of LT (LT-A and LT-B) and confirmed previous observations (6) on the amino acid sequence homology between the B subunits of choleragen and of LT. The genes encoding LT biosynthesis in a human isolate, strain H10407, were identified by Yamamoto and Yokata (28) , and the fragments specific for the A and B subunits.were subsequently cloned onto separate carrier plasmids (29, 30) .
Much of the emphasis of the previous work has been on the construction of a strain of E. coli which produces only LT-B for potential use as a live oral vaccine. Such a strain would be analogous to the strain of V. cholerae constructed by Honda and Finkelstein (15) Transformation. Transformation of E. coli MM294 was carried out as described by Bolivar and Backman (1) . Cells were made competent by incubation in 30 mM CaCl2 at 0°C for 20 min. Samples containing 0.2 ml of 10-fold-concentrated cells were added to DNA in 0.1 ml of cold ligation buffer supplemented with 30 mM CaCl2 and incubated at 0°C for 1 h. The cells were then heated to 370C for 2 min and held at room temperature for 10 min before being diluted into 4 ml of L broth. The cells were incubated at 37°C for 3 h, and transformants were selected on Trypticase soy agar (BBL Microbiology Systems, Cockeysville, Md.) containing appropriate antibiotics. Fragments cloned into the tetracycline resistance gene of pBR322 were selected for by cycloserine enrichment before plating for selection (1) . After 18 h of incubation in L broth containing 50 ,ug of ampicillin per ml, the culture was diluted 1:100 into fresh medium and supplemented with 4 ,ug of tetracycline per ml. After a 45-min incubation, 100 p.g of D-cycloserine was added per ml, and incubation was continued for an additional 2 h. The culture was then centrifuged, and the pellet was resuspended in 20 ml of L broth. After 3 h of incubation, 0.1-ml aliquots were plated on Trypticase soy agar containing 50 ,ug of ampicillin per ml. A total of 96% of the clones obtained by cycloserine enrichment were ampicillin resistant (Apr) and tetracycline sensitive (Tcs).
Bioassay. Assays in mouse Y1 adrenal cells were performed essentially as described by Sack and Sack (21) .
ELISA. The enzyme-linked immunosorbent assay (ELISA) for LT was performed as previously described (17) except that the microtiter wells were precoated with 50 ,ug of type III gangliosides (Sigma Chemical Co., St. Louis, Mo.) per ml. This modification has been shown to increase the sensitivity of the assay 10-fold and is specific for compounds that bind to ganglioside and react with antiserum to LT. Clones to be assayed were cultured overnight in 20 ml of Trypticase soy broth (BBL), centrifuged, suspended in 2 ml of TEAN buffer (0.05 M Tris, 0.001 M EDTA, 0.003 M NaN3, 0.2 M NaCl [pH 7.5]) (2), and lysed by sonication. Lysates were clarified by centrifugation and serially diluted in phosphate-buffered saline (pH 7.4)-0.05% Tween 20.
Purification of LT and LT-B. The culture conditions and purification of LT and LT-B were as previously described (2, 3) . Organisms were cultured overnight in 10 liters of Evans medium (10) at 37°C with vigorous aeration and agitation after inoculation with 106 viable bacteria per ml. The bacteria were harvested by centrifugation at 4°C, and the cells were suspended in TEAN and lysed by sonication. The crude lysate was clarified by centrifugation and precipitated with 60% saturated (NH4)2SO4. The precipitate was then harvested and dialyzed against TEAN and LT or LT-B purified by agarose affinity chromatography (4).
Enterotoxin subunits. Analysis of the A and B subunits of LT and of LT-B was performed by gel filtration under dissociating conditions as described previously (6) .
Antisera. Antiserum to LT-B was prepared by immunizing a goat with 1 mg of guanidine-purified LT-B (6) suspended in 2 ml of Freund complete adjuvant. Antiserum to the A subunit of cholera toxin was prepared as previously described (2) .
Guidelines used for recombinant DNA experiments. The experiments reported here were performed using Pl-EK1 conditions as specified in the Guidelines for Recombinant DNA Technology published by the National Institutes of Health.
RESULTS

Isolation of pDF82. E. coli 711(10407) is an
LT' ST' transconjugant. This strain was derived by phenotypically tagging the enterotoxin plasmid of E. coli H10407 by transposition from an F'ts lac::TnS plasmid and conjugally transferring the TnS-tagged plasmid to E. coli K-12 strain 711 (5). The 10407 plasmid was purified, cut with the restriction endonuclease PstI, and ligated with T4 DNA ligase to pBR322 which had been cut with PstI and treated with alkaline phosphatase. The ligation mixture was used to transform E. coli MM294, and Aps Tcr transformants were identified (185 of the 6,484 Tcr transformants screened were Aps). These trans- (19) . Each tube contained 10 ,ug of protein as determined by the method of Lowry et al. (20) . The band near the bottom of each gel (TD) is the tracking dye. subunit (lower band). As expected, the peak eluted by galactose from pDF87 (Fig. 2, lane B) contained only a single band representing the oligomeric B subunit. Even when the gels were overloaded with as much as 100 ,ug of protein, no band corresponding to the A subunit was visible in SDS-PAGE.
Each peak was then examined by gel filtration under dissociating conditions. Figure 3 shows the chromatographic profile of each preparation when applied to a Sephadex G-75 column in the presence of 5 M guanidine. The profile from pDF82 showed two peaks, the first corresponding to the A subunit and the second corresponding to the monomeric B subunit of LT. In contrast, pDF87 contained only a single peak corresponding to the monomeric B subunit. Thus, pDF87 produced only the B subunit of LT, and that subunit was structurally indistinguishable from LT-B produced as a component of the LT holotoxin.
When assayed by ELISA against antiserum to LT-B and antiserum to cholera toxin subunit A, pDF82 was shown to produce holotoxin which reacted with both subunit antisera (Fig. 4) . LT-B produced by pDF87 was immunologically identical to that produced by pDF82, but did not contain antigen which was recognized by antiserum to cholera toxin subunit A. No demonstrable A antigen was present, even at 10 ,ug, an amount 4,000-fold-higher than the limit of resolution in this assay (data not shown). 4 . ELISA comparison of agarose affinity-purified preparations from pDF82 and pDF87, using monospecific antiserum to LT-B and to cholera toxin subunit A (cholera-A). pDF87 did not produce antigen which was recognized by antiserum to cholera-A. Samples were assayed in twofold serial dilutions in phosphate-buffered saline- Tween 20. ly purified B subunit from that clone by agarose affinity chromatography. Others have cloned the gene fragments for LT-A and LT-B onto a variety of plasmid vehicles (7, 22, 29, 30) is able to transcribe DNA inserted into the Hindlll site in the tetracycline resistance region (27) . This would be particularly important since the B gene contains no identifiable promoter region and presumably is transcribed from the A subunit promoter in vivo (8) . After sequential digestion of the enterotoxin plasmid of human isolate H10407 with PstI and HindIlI and transformation of E. coli MM294, a clone was selected which was negative in the mouse Y1 adrenal tumor cell assay and positive in ELISA for B antigen. Analysis by agarose gel electrophoresis revealed only a single plasmid consisting of pBR322 and a 0.8-kb HindIll fragment coding for LT-B. These findings are consistent with those of Yamamoto et al. (30) , who inserted a 0.77-kb HindlIl fragment of isolate H10407 into plasmid pACYC177, and of Sanchez et al. (22) , who recently reported the construction of an LT-B recombinant plasmid by insertion of a 0.8-kb HindlIl fragment from pEWD299 (8), derived from porcine strain P307, into the plasmid vehicle pACYC184.
It is not possible to predict whether the gene product of our clone is identical to that produced by other clones constructed elsewhere. Diverse results are often obtained when a particular gene fragment is inserted into different cloning vehicles or into different sites on the same vehicle (27) . Our intent was to construct a clone that would produce significant amounts of LT-B that could be purified by existing procedures. The nature of the galactose-binding region of the B subunit is unknown, but alterations in structure resulting from deletion or gene fusion could interfere with that binding and hamper purification. Since galactose binding is presumably a reflection of the affinity of LT for its native receptor, GM1, the use of the ganglioside-ELISA for selection of antigen-producing clones eliminated any in which the galactose-binding capability of the B subunit was significantly impaired. Likewise, minor alterations could have had a profound influence on immunological determinants within the molecule. LT-B produced by this clone was immunologically indistinguishable from native B subunit.
LT-B produced in this manner has considerable potential as a component of a vaccine designed to stimulate immunity against enterotoxigenic E. coli. We have shown (17a) that B subunit can be cross-linked to synthetically derived ST and that this immunogen evokes a fourto sevenfold increase over control values of serum immunoglobulin G and mucosal secretary immunoglobulin A antitoxin levels to each of the component toxins, thus providing significant (P < 0.001) protection against either toxin or heterologous serotypes of viable strains which produce these toxins. The construction of a clone of E. coli which produces only LT-B allows the production of B subunit under conditions which are relatively rapid, less expensive than existing methods, and, more importantly, free of contaminating subunit A.
